NEW YORK (GenomeWeb News) – Ingenuity Systems today said that AstraZeneca has signed a multi-year deal to use the firm's Ingenuity Pathways Analysis software in its research and target discovery programs.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.
A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.
A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.
The BabySeq project to study the risks and benefits of sequencing newborns is underway.